<p>Groups of mice (<i>n</i> = 10/group) were immunized i.n. with single H5N1 influenza split vaccines (3 µg HA per dose) and a trivalent vaccine that contained 1 µg HA per dose of each single vaccine in combination with adjuvant and challenged i.n. with 50LD<sub>50</sub> OT/SZ/097/03 virus suspension. Mice were monitored for weight change (A) and survival rates (B) throughout a 14-day observation period.</p
<p>Mouse groups were immunized with 1203HA, 05HA, H5b, H7HA, H9HA, H7H9b, H5b+H7H9b or ΔE1E3 twice a...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>Six-week-old female BALB/c mice (n = 6) were immunized twice with 10 ug of 3M2eC protein plus 2 u...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>Mice were immunized i.n. with single H5N1 influenza split vaccines (3 µg HA per dose) and a triva...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>Mice were challenged one month after vaccination (0.5 µg PZQ/0.1 µg antigen). (A) Viral loads in ...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>HA1-Fc- and HA1-Fdc-vaccinated mice were challenged with 10 LD<sub>50</sub> of three clades (clad...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Survival rates (A, C) and body weight changes (B, D) of BALB/c mice after i.n. challenge with 20×...
<p>Mouse groups were immunized with 1203HA, 05HA, H5b, H7HA, H9HA, H7H9b, H5b+H7H9b or ΔE1E3 twice a...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>Six-week-old female BALB/c mice (n = 6) were immunized twice with 10 ug of 3M2eC protein plus 2 u...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>Each group of mice was immunized i.m. two times on days 0 and 28 with MVAtor-tri-HA or MVAtor-mon...
<p>Mice were immunized i.n. with single H5N1 influenza split vaccines (3 µg HA per dose) and a triva...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>Mice were challenged one month after vaccination (0.5 µg PZQ/0.1 µg antigen). (A) Viral loads in ...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>HA1-Fc- and HA1-Fdc-vaccinated mice were challenged with 10 LD<sub>50</sub> of three clades (clad...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>Survival rates (A, C) and body weight changes (B, D) of BALB/c mice after i.n. challenge with 20×...
<p>Mouse groups were immunized with 1203HA, 05HA, H5b, H7HA, H9HA, H7H9b, H5b+H7H9b or ΔE1E3 twice a...
<p>Mice were immunized and boosted with various doses of Ad4 and Ad5 expressing the H3-Con consensus...
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...